110 related articles for article (PubMed ID: 22017969)
21. Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats.
Navarra RL; Clark BD; Zitnik GA; Waterhouse BD
Exp Clin Psychopharmacol; 2013 Oct; 21(5):363-74. PubMed ID: 24099357
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate and atomoxetine inhibit social play behavior through prefrontal and subcortical limbic mechanisms in rats.
Achterberg EJ; van Kerkhof LW; Damsteegt R; Trezza V; Vanderschuren LJ
J Neurosci; 2015 Jan; 35(1):161-9. PubMed ID: 25568111
[TBL] [Abstract][Full Text] [Related]
23. Visualizing Neuropharmacological Effects of Guanfacine Extended Release in Attention Deficit Hyperactivity Disorder Using Functional Near-Infrared Spectroscopy.
Ikeda T; Inoue A; Tanaka D; Hashimoto T; Sutoko S; Tokuda T; Kyutoku Y; Maki A; Yamagata T; Dan I; Monden Y
Front Neuroergon; 2021; 2():657657. PubMed ID: 38235230
[No Abstract] [Full Text] [Related]
24. [Formula: see text] Does training working memory or inhibitory control produce far-transfer improvements in set shifting for children with ADHD? A randomized controlled trial.
Irwin Harper LN; Groves NB; Marsh CL; Cole AM; Kofler MJ
Child Neuropsychol; 2023 Jul; 29(5):825-845. PubMed ID: 36331068
[TBL] [Abstract][Full Text] [Related]
25. Superior Vena Cava Flow in Children With Attention Deficit Hyperactivity Disorder.
Karabulut M; Yıldırım K
Psychiatry Investig; 2023 Sep; 20(9):888-895. PubMed ID: 37794671
[TBL] [Abstract][Full Text] [Related]
26. Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHD.
Kaiser A; Aggensteiner PM; Blasco Fontecilla H; Ros T; Acquaviva E; Attal Y; Banaschewski T; Baumeister S; Bousquet E; Bussalb A; Delhaye M; Delorme R; Drechsler R; Goujon A; Häge A; Mayaud L; Mechler K; Menache C; Revol O; Tagwerker F; Walitza S; Werling AM; Bioulac S; Purper-Ouakil D; Brandeis D
Front Psychiatry; 2023; 14():1331004. PubMed ID: 38312916
[TBL] [Abstract][Full Text] [Related]
27. Effects of Long-Term Use of Prescription Methylphenidate on Myocardial Performance in Children with Attention-Deficit/Hyperactivity Disorder: A Tissue Doppler Imaging Study.
Kara T; Mutlu Mıhçıoğlu A; Yılmaz S; Akaltun İ
J Child Adolesc Psychopharmacol; 2018 Nov; ():. PubMed ID: 30388033
[TBL] [Abstract][Full Text] [Related]
28. Neuropsychological factors associated with performance on the rey-osterrieth complex figure test in children with neurofibromatosis type 1.
Maier A; Pride NA; Hearps SJC; Shah N; Porter M; North KN; Payne JM
Child Neuropsychol; 2024 Feb; 30(2):348-359. PubMed ID: 37038321
[TBL] [Abstract][Full Text] [Related]
29. Effects of Atomoxetine Hydrochloride on Regulation of Lifespan in Drosophila Model.
Shen J; Shan J; Liang B; Zhang D; Tang H; Zhong L; Li M
J Nutr Health Aging; 2022; 26(2):203-208. PubMed ID: 35166316
[TBL] [Abstract][Full Text] [Related]
30. Neuropsychological Profile of College Students Who Engage in Binge Drinking.
Kang JG; Kim MS
Front Psychol; 2022; 13():873654. PubMed ID: 35496236
[TBL] [Abstract][Full Text] [Related]
31. Effect of yoga program on executive functions of adolescents dwelling in an orphan home: A randomized controlled study.
Purohit SP; Pradhan B
J Tradit Complement Med; 2017 Jan; 7(1):99-105. PubMed ID: 28053894
[TBL] [Abstract][Full Text] [Related]
32. Effects of Atomoxetine and Osmotic Release Oral System-Methylphenidate on Executive Functions in Patients with Combined Type Attention-Deficit/Hyperactivity Disorder.
Ince Tasdelen B; Karakaya E; Oztop DB
J Child Adolesc Psychopharmacol; 2015 Aug; 25(6):494-500. PubMed ID: 26218871
[TBL] [Abstract][Full Text] [Related]
33. Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder.
Bédard AC; Stein MA; Halperin JM; Krone B; Rajwan E; Newcorn JH
J Child Psychol Psychiatry; 2015 Jan; 56(1):40-8. PubMed ID: 24942409
[TBL] [Abstract][Full Text] [Related]
34. Atomoxetine effects on executive function as measured by the BRIEF--a in young adults with ADHD: a randomized, double-blind, placebo-controlled study.
Adler LA; Clemow DB; Williams DW; Durell TM
PLoS One; 2014; 9(8):e104175. PubMed ID: 25148243
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit/hyperactivity disorder: a head-to-head, randomized, double-blind, phase IIIb study.
Dittmann RW; Cardo E; Nagy P; Anderson CS; Bloomfield R; Caballero B; Higgins N; Hodgkins P; Lyne A; Civil R; Coghill D
CNS Drugs; 2013 Dec; 27(12):1081-92. PubMed ID: 23959815
[TBL] [Abstract][Full Text] [Related]
36. Safety of Methylphenidate and Atomoxetine in Children with Attention-Deficit/Hyperactivity Disorder (ADHD): Data from the Italian National ADHD Registry.
Cortese S; Panei P; Arcieri R; Germinario EA; Capuano A; Margari L; Chiarotti F; Curatolo P
CNS Drugs; 2015; 29(10):865-77. PubMed ID: 26293742
[TBL] [Abstract][Full Text] [Related]
37. Long-term quality-of-life and functioning comparison of atomoxetine versus other standard treatment in pediatric attention-deficit/hyperactivity disorder.
Fuentes J; Danckaerts M; Cardo E; Puvanendran K; Berquin P; De Bruyckere K; Montoya A; Quail D; Escobar R
J Clin Psychopharmacol; 2013 Dec; 33(6):766-74. PubMed ID: 23963057
[TBL] [Abstract][Full Text] [Related]
38. European, randomized, phase 3 study of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder.
Coghill D; Banaschewski T; Lecendreux M; Soutullo C; Johnson M; Zuddas A; Anderson C; Civil R; Higgins N; Lyne A; Squires L
Eur Neuropsychopharmacol; 2013 Oct; 23(10):1208-18. PubMed ID: 23332456
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy and acceptability of methylphenidate and atomoxetine in treatment of attention deficit hyperactivity disorder in children and adolescents: a meta-analysis.
Hanwella R; Senanayake M; de Silva V
BMC Psychiatry; 2011 Nov; 11():176. PubMed ID: 22074258
[TBL] [Abstract][Full Text] [Related]
40. The effects of stimulant medication on working memory functional connectivity in attention-deficit/hyperactivity disorder.
Wong CG; Stevens MC
Biol Psychiatry; 2012 Mar; 71(5):458-66. PubMed ID: 22209640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
